The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia

Tanja Novakovic; Antony P. Martin; Mark Parker; Alessandra Ferrario; Simo Vukovic; Krzysztof Łanda; Jaroslav Duba; Dávid Dankó; Nikolaos Kotsopoulos; Brian Godman; Jelena Ristic; Danka Stefanovic; Danka Tesic

doi:10.1080/14737167.2017.1385394

The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia

Tanja Novakovic, Antony P. Martin, Mark Parker, Alessandra Ferrario, Simo Vukovic, Krzysztof Łanda, Jaroslav Duba, Dávid Dankó, Nikolaos Kotsopoulos, Brian Godman^*, Jelena Ristic, Danka Stefanovic, Danka Tesic

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.

Original language	English
Pages (from-to)	519-521
Number of pages	3
Journal	Expert Review of Pharmacoeconomics and Outcomes Research
Volume	17
Issue number	6
DOIs	https://doi.org/10.1080/14737167.2017.1385394
Publication status	Published - 2 Nov 2017
Externally published	Yes

Keywords

Central and Eastern Europe
Serbia
health technology assessment
innovation
managed entry agreements

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/14737167.2017.1385394

Cite this

Novakovic, T., Martin, A. P., Parker, M., Ferrario, A., Vukovic, S., Łanda, K., Duba, J., Dankó, D., Kotsopoulos, N., Godman, B., Ristic, J., Stefanovic, D., & Tesic, D. (2017). The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia. Expert Review of Pharmacoeconomics and Outcomes Research, 17(6), 519-521. https://doi.org/10.1080/14737167.2017.1385394

@article{32bcabf0a2ad4648b3959b784d33932b,

title = "The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia",

abstract = "The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.",

keywords = "Central and Eastern Europe, Serbia, health technology assessment, innovation, managed entry agreements",

author = "Tanja Novakovic and Martin, {Antony P.} and Mark Parker and Alessandra Ferrario and Simo Vukovic and Krzysztof {\L}anda and Jaroslav Duba and D{\'a}vid Dank{\'o} and Nikolaos Kotsopoulos and Brian Godman and Jelena Ristic and Danka Stefanovic and Danka Tesic",

note = "Publisher Copyright: {\textcopyright} 2017 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2017",

month = nov,

day = "2",

doi = "10.1080/14737167.2017.1385394",

language = "English",

volume = "17",

pages = "519--521",

journal = "Expert Review of Pharmacoeconomics and Outcomes Research",

issn = "1473-7167",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

Novakovic, T, Martin, AP, Parker, M, Ferrario, A, Vukovic, S, Łanda, K, Duba, J, Dankó, D, Kotsopoulos, N, Godman, B, Ristic, J, Stefanovic, D & Tesic, D 2017, 'The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 17, no. 6, pp. 519-521. https://doi.org/10.1080/14737167.2017.1385394

The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia. / Novakovic, Tanja; Martin, Antony P.; Parker, Mark et al.
In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 17, No. 6, 02.11.2017, p. 519-521.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia

AU - Novakovic, Tanja

AU - Martin, Antony P.

AU - Parker, Mark

AU - Ferrario, Alessandra

AU - Vukovic, Simo

AU - Łanda, Krzysztof

AU - Duba, Jaroslav

AU - Dankó, Dávid

AU - Kotsopoulos, Nikolaos

AU - Godman, Brian

AU - Ristic, Jelena

AU - Stefanovic, Danka

AU - Tesic, Danka

PY - 2017/11/2

Y1 - 2017/11/2

N2 - The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.

AB - The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.

KW - Central and Eastern Europe

KW - Serbia

KW - health technology assessment

KW - innovation

KW - managed entry agreements

UR - http://www.scopus.com/inward/record.url?scp=85030871262&partnerID=8YFLogxK

U2 - 10.1080/14737167.2017.1385394

DO - 10.1080/14737167.2017.1385394

M3 - Article

C2 - 28946800

AN - SCOPUS:85030871262

SN - 1473-7167

VL - 17

SP - 519

EP - 521

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

IS - 6

ER -

The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this